FDA Advisory Committee Votes in Favor of Ide-Cel for Adult Patients With Multiple Myeloma

Source: Pharmacy Times articles

The decision to vote in favor of idecabtagene vicleucel comes after positive phase 3 trial results demonstrating its efficacy compared with standard regimens.
Read More